KNSA Kiniksa Pharmaceuticals, Ltd.
Healthcare$52.86-0.71%ClosedMarket Cap: $3.97B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$64.00
Target (Median)
$62.00
Target Range
$59.00 - $71.00
Upside from current price: 21.1%
Rating Distribution
1 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-29 | Citigroup | maintain | Buy | Buy |
| 2026-04-29 | Wedbush | maintain | Outperform | Outperform |
| 2026-04-29 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-04-29 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-04-28 | Jefferies | maintain | Buy | Buy |
| 2026-02-25 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-02-25 | Wedbush | maintain | Outperform | Outperform |
| 2026-01-13 | Wedbush | maintain | Outperform | Outperform |
| 2025-10-29 | Goldman Sachs | maintain | Buy | Buy |
| 2025-10-17 | Citigroup | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $1.89 | $1.13B | 4 |
| Sun Dec 31 | $2.50 | $1.27B | 6 |
| Mon Dec 31 | $2.96 | $1.43B | 4 |
| Tue Dec 31 | $4.43 | $1.58B | 2 |